IBB Among Technology ETFs
End-of-day Nov 18, 2026 · 54 Technology ETFs by YTD
Getting the latest data.
| Returns | Today | 1W | 1M | 3M | YTD | 1Y | 3Y | 5Y | 10Y | Max |
|---|---|---|---|---|---|---|---|---|---|---|
| Total return | −0.8% | −5.8% | −2.4% | −2.6% | +21.8% | +24.5% | +79.2% | +35.5% | +141.6% | +690.0% |
| Peer average | +0.3% | −6.2% | −9.7% | −12.1% | +2.0% | +5.0% | +65.2% | +23.5% | +365.5% | — |
| S&P 500 · VOO | −0.3% | −3.9% | −5.0% | −4.0% | +8.0% | +10.9% | +72.4% | +68.9% | +302.1% | — |
$94 of every $1,000 in IBB is Gilead
| # | ||||||
|---|---|---|---|---|---|---|
| 1 | GILDGilead Sciences | Healthcare | 9.38% | $937.57 | 6.1M | $1.03B |
| 2 | AMGNAmgen | Healthcare | 8.58% | $858.43 | 2.1M | $945.0M |
| 3 | VRTXVertex Pharmaceuticals | Healthcare | 7.91% | $790.58 | 1.6M | $870.3M |
| 4 | REGNRegeneron Pharmaceuticals | Healthcare | 6.77% | $676.89 | 778K | $745.2M |
| 5 | MRNAModerna | Healthcare | 5.39% | $538.70 | 2.9M | $593.1M |
| 6 | ARGXArgenx SE | Healthcare | 3.75% | $375.42 | 436K | $413.3M |
| 7 | NTRANatera | Healthcare | 2.76% | $275.99 | 1.1M | $303.8M |
| 8 | BIIBBiogen | Healthcare | 2.62% | $262.26 | 1.2M | $288.7M |
| 9 | ONCBeone Medicines AG | Healthcare | 2.48% | $247.88 | 660K | $272.9M |
| 10 | RVMDRevolution Medicines | Healthcare | 2.24% | $223.64 | 1.5M | $246.2M |
| 11 | ILMNIllumina | Healthcare | 2.18% | $217.59 | 1.2M | $239.5M |
| 12 | GMABGenmab Sponsored | Healthcare | 2.05% | $205.23 | 4.3M | $225.9M |
| 13 | INSMInsmed | Healthcare | 1.87% | $186.93 | 1.7M | $205.8M |
| 14 | UTHRUnited Therapeutics | Healthcare | 1.73% | $172.68 | 325K | $190.1M |
| 15 | INCYIncyte | Healthcare | 1.71% | $170.58 | 1.6M | $187.8M |
of the $347B in 58 Technology ETFs
| # | Ticker | Company | Weight ▼ |
|---|---|---|---|
| 1 | GILD | Gilead Sciences | 9.38% |
| 2 | AMGN | Amgen | 8.58% |
| 3 | VRTX | Vertex Pharmaceuticals | 7.91% |
| 4 | REGN | Regeneron Pharmaceuticals | 6.77% |
| 5 | MRNA | Moderna | 5.39% |
| 6 | ARGX | Argenx SE | 3.75% |
| 7 | NTRA | Natera | 2.76% |
| 8 | BIIB | Biogen | 2.62% |
| 9 | ONC | Beone Medicines AG | 2.48% |
| 10 | RVMD | Revolution Medicines | 2.24% |
Estimated yearly cost excludes trading costs and assumes constant assets.
| Ex-date | Paid | Per share |
|---|---|---|
| Sep 15, 2026 | Sep 18, 2026 | $0.0112 |
| Jun 15, 2026 | Jun 18, 2026 | $0.0238 |
| Mar 17, 2026 | Mar 20, 2026 | $0.12 |
| Dec 16, 2025 | Dec 19, 2025 | $0.18 |
| Sep 16, 2025 | Sep 19, 2025 | $0.0828 |
| Mar 18, 2025 | Mar 21, 2025 | $0.12 |
| Dec 17, 2024 | Dec 20, 2024 | $0.0624 |
| Sep 25, 2024 | Sep 30, 2024 | $0.20 |
| Mar 21, 2024 | Mar 27, 2024 | $0.13 |
| Dec 20, 2023 | Dec 27, 2023 | $0.12 |
| Sep 26, 2023 | Oct 2, 2023 | $0.15 |
| Jun 7, 2023 | Jun 13, 2023 | $0.0062 |